UnitedHealth Maintaining Tier 2 Formulary Status For Vytorin
Executive Summary
UnitedHealth Group will retain the current tier 2 formulary placement - preferred brand - for Vytorin (ezetimibe/simvastatin) in both its commercial and Medicare Part D formularies because the recently-released ENHANCE data do not indicate any safety issues with the drug, the firm said